Vaccination Coverage and Uptake in Young People Experiencing or at Risk of Homelessness
NCT04864678 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 400
Last updated 2022-01-28
Summary
This retrospective audit will investigate if young people who are homeless or at risk of homelessness in Melbourne were up-to-date with routine childhood and adolescent vaccines on first encounter with a nurse-led primary health clinic (the Young People's Health Service), and if they commenced and completed immunisation catch-up plans following referral to the Young People's Health Service immunisation nurse.
The purpose of the proposed study is to establish baseline immunisation coverage within the targeted population, then to explore the impact of an immunisation nurse role on immunisation coverage in a population of young people aged 15-24 years who are experiencing or at risk of homelessness.
The Young People's Health Service is a program of the Royal Children's Hospital Department of Adolescent Medicine. The data collected will be sourced solely from the Royal Children's Hospital Electronic Medical Records.
Conditions
- Homeless Youth
Interventions
- OTHER
-
Referral to the Young People's Health Service immunisation nurse
Young people who have been referred to an immunisation nurse at the Young People's Health Service.
Sponsors & Collaborators
-
RCH League of Former Trainees and Associates Inc
collaborator UNKNOWN -
Royal Children's Hospital
collaborator OTHER -
Murdoch Childrens Research Institute
lead OTHER
Principal Investigators
-
Belinda L Tominc, MNSc · Royal Children's Hospital
Eligibility
- Min Age
- 15 Years
- Max Age
- 24 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-05-21
- Primary Completion
- 2021-11-17
- Completion
- 2021-12-09
Countries
- Australia
Study Locations
More Related Trials
-
BCG Revaccination in Children and Adolescents
NCT05330884 ·Status: SUSPENDED ·Phase: PHASE3
-
Increasing Vaccine Uptake Among Adolescents in the Rural South
NCT04999267 ·Status: COMPLETED ·Phase: NA
-
A Phase I Study of the Safety and Immunogenicity of a Recombinant MVA Vaccine Encoding a Secreted Antigen From M. Tuberculosis, Antigen 85A, Delivered Intradermally by a Needle Injection in Healthy Volunteers Who Have Received BCG Immunisation 1 Month Previously
NCT00427453 ·Status: COMPLETED ·Phase: PHASE1
-
Immunisation History Survey - a Study to Measure Levels of Immunity to Routine Immunisations
NCT03145324 ·Status: COMPLETED
-
mHealth-Assisted Conditional Cash Transfers to Improve Timeliness of Vaccinations (D0271)
NCT03252288 ·Status: COMPLETED ·Phase: NA
-
Safety and Immunogenicity of VPM1002 Vaccination or BCG Revaccination Against TB in Pre-Adolescents Living With and Without HIV in South Africa
NCT05539989 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
A Phase I Study of the Safety and Immunogenicity of a Recombinant MVA Vaccine Encoding a Secreted Antigen From M. Tuberculosis, Antigen 85A, Delivered Intradermally by a Needle Injection in Healthy Volunteers Who Have Previously Received BCG
NCT00427830 ·Status: COMPLETED ·Phase: PHASE1
-
Randomized Controlled Trial of Percutaneous and Intradermal BCG Vaccination.
NCT00242047 ·Status: UNKNOWN ·Phase: PHASE4
-
The Safety and Immunogenicity of a TB Vaccine; MVA85A, in Healthy Volunteers Who Are Infected With HIV
NCT00395720 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of 2 Doses of a New TB Vaccine, MVA85A, in Healthy Volunteers Previously Vaccinated With BCG
NCT00465465 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of MVA85A, in Asymptomatic Volunteers Infected With TB, HIV or Both
NCT00480558 ·Status: COMPLETED ·Phase: PHASE1
-
Impact of the WHO Recommended Vitamin A Supplementation at Immunisation Contacts
NCT00514891 ·Status: TERMINATED ·Phase: PHASE4
-
Evaluation of Patients' Knowledge of Their Vaccination Status and Their Relationship to Vaccination at Melun Hospital
NCT06616753 ·Status: RECRUITING
-
Safety of Tuberculosis Vaccine, MVA85A, Administered by the Intramuscular Route and the Intradermal Route
NCT01181856 ·Status: COMPLETED ·Phase: PHASE1
-
Safety of Tuberculosis Vaccine, MVA85A, Administered by the Aerosol Route and the Intradermal Route
NCT01497769 ·Status: COMPLETED ·Phase: PHASE1
-
The Next Generation Vaccine Card: Innovative Technology to Improve Vaccine Equity in Rural and Urban Settings in East Africa
NCT06470919 ·Status: COMPLETED ·Phase: NA
-
A Clinical Trial to Assess the Safety of a Measles Vaccine (Dry Powder) Administered by Two Different Devices
NCT01557699 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase I Study of the Safety and Immunogenicity of MVA85A in Healthy Gambian Volunteers
NCT00423839 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Immunogenicity of MVA85A in Volunteers Latently Infected With TB.
NCT00456183 ·Status: COMPLETED ·Phase: PHASE1
-
Earlier Prime-BOOST Schedule to Improve MEasles Protection in High Burden Settings
NCT06667206 ·Status: RECRUITING ·Phase: PHASE2
-
Safety and Immunogenicity of MVA85A Prime and Bacille Calmette-Guerin Boost Vaccination
NCT01650389 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Immunogenicity of MVA85A, in Healthy Volunteers in Cape Town
NCT00460590 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine in Healthy HIV Negative Adolescents
NCT00950612 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase I Study of a New Tuberculosis (TB) Vaccine, MVA85A, in Healthy Volunteers With HIV
NCT00731471 ·Status: COMPLETED ·Phase: PHASE1
-
Immunogenicity and Safety of a Candidate Tuberculosis (TB) Vaccine Given to Healthy Adults in a TB-endemic Region
NCT00600782 ·Status: COMPLETED ·Phase: PHASE2